Adaptive Biotechnologies Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Commercial Services » Miscellaneous Commercial Services
ETSYEtsy, Inc. 1.29%156.617.5%$659.01m
FLTFleetCor Technologies, Inc. -0.26%263.123.6%$237.68m
EFXEquifax, Inc. 0.78%165.892.0%$170.25m
CHGGChegg, Inc. 1.76%77.3714.8%$165.84m
CPRTCopart, Inc. -0.02%113.284.4%$162.81m
MARAMarathon Patent Group, Inc. 0.87%5.810.8%$145.18m
SHCSotera Health Co. -0.45%27.880.0%$137.27m
CDAYCeridian HCM Holding, Inc. 2.30%96.060.0%$134.68m
MRVIMaravai Lifesciences Holdings, Inc. -1.14%27.800.0%$126.34m
PAGSPagSeguro Digital Ltd. 1.90%48.880.0%$92.65m, Inc. 1.30%189.7124.0%$87.81m
BANDBandwidth, Inc. 1.93%160.540.0%$81.91m
ITGartner, Inc. 0.63%155.072.4%$74.47m
CRLCharles River Laboratories International, Inc. 0.29%236.144.5%$68.97m
CDKCDK Global, Inc. 0.25%48.482.3%$67.63m

Company Profile

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.